Pradaxa Statistics and the Elderly

Pradaxa in elderly patients is of particular concern because the greatest number of patients taking Pradaxa are elderly.

Quarter Watch is an independent publication of the Institute for Safe Medication Practices (ISMP) that alerts the public to drug dangers based on research studies. It reported that the median age of patients suffering from adverse Pradaxa side effects was 80 years old. Patients who were the most vulnerable for hemorrhaging based on drug overdoses were the elderly and 25 percent of the patients affected were 84 years of age or older. Research also shows that, because the FDA approved the Pradaxa dosage at 150 milligrams twice per day (except for patients with renal impairment), this may have led to overdosing for the elderly, who require individualized dosages based on their physical conditions.

Failing kidney function is another factor for the elderly, because Pradaxa levels in the blood can increase by 50 percent with mild kidney impairment and by 300 percent with moderate kidney impairment. Other ISMP reports indicate that Pradaxa was the most suspect drug in 2011 based on the fact that the Food and Drug Administration (FDA) received more direct reports about adverse side effects for Pradaxa than any other drug. The FDA received 817 Pradaxa reports and 490 Coumadin reports.

If your elderly loved one suffered adverse side effects because of Pradaxa, consult with attorneys who have experience handling elderly Pradaxa cases.

Phillips Law Offices works with families to recover compensation and hold pharmaceutical companies accountable for adverse side effects.